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Randomized Comparison of Transradial
ersus Transfemoral Approach for Coronary
ngiography and Angioplasty
artin Brueck, MD,* Dirk Bandorski, MD,* Wilfried Kramer, MD,*
arcus Wieczorek, MD,† Reinhard Höltgen, MD,† Harald Tillmanns, MD‡
etzlar, Duisburg, and Giessen, Germany
bjectives The aim of the study was to evaluate the safety, feasibility, and procedural variables by
he transradial approach compared with the transfemoral access in a standard population of pa-
ients undergoing coronary catheterization.
ackground Coronary catheterization is usually performed via the transfemoral approach. Transra-
ial access may offer some advantages in comparison with transfemoral access especially under
onditions of aggressive anticoagulation and antiplatelet treatment.
ethods Between July 2006 and January 2008, a total of 1,024 patients undergoing coronary cath-
terization were randomly assigned to the transradial or transfemoral approach. Patients with an
bnormal Allen’s test, history of coronary artery bypass surgery, simultaneous right heart catheter-
zation, chronic renal insufﬁciency, or known difﬁculties with the radial or femoral access were
xcluded.
esults Successful catheterization was achieved in 494 of 512 patients (96.5%) in the transradial
nd in 511 of 512 patients (99.8%) in the transfemoral group (p  0.0001). Median procedural dura-
ion (37.0 min, interquartile range [IQR] 19.6 to 49.1 min vs. 40.2 min, IQR 24.3 to 50.8 min; p 
.046) and median dose area product (38.2 Gycm2, IQR 20.4 to 48.5 Gycm2 vs. 41.9 Gycm2, IQR 22.6
o 52.2 Gycm2; p  0.034) were signiﬁcantly lower in the transfemoral group compared with the
ransradial access group. A median amount of contrast agent was similar among both groups. Vas-
ular access site complications were higher in the transfemoral group (3.71%) than in the transradial
roup (0.58%; p  0.0008)
onclusions The ﬁndings of the present study show that transradial coronary angiography and an-
ioplasty are safe, feasible, and effective with similar results to those of the transfemoral approach.
owever, procedural duration and radiation exposure are higher using the transradial access. In con-
rast to the transfemoral route, the rate of major vascular complications was negligible using the
ransradial approach. (J Am Coll Cardiol Intv 2009;2:1047–54) © 2009 by the American College of
ardiology Foundation
rom the *Department of Cardiology, Clinic of Wetzlar, Wetzlar, Germany; †Department of Cardiology, Evangelisches und
ohanniter Klinikum Niederrhein gGmbH, Duisburg, Germany; and ‡Department of Cardiology, University of Giessen, Giessen,
ermany. This study was presented as an oral contribution at the 58th Annual Scientific Session of the American College of
ardiology, March 28 to 31, 2009, in Orlando, Florida, and as a poster presentation at the 75th Annual Meeting of the German
ociety of Cardiology, April 16 to 18, 2009, in Mannheim, Germany.anuscript received July 13, 2009; accepted July 25, 2009.
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1048oronary angiography and angioplasty are usually per-
ormed via the transfemoral approach. Transradial access for
oronary artery catheterization offers some advantages in
omparison with the transfemoral route. Especially under
onditions of aggressive anticoagulation and antiplatelet
reatment, vascular bleeding complications at the femoral
uncture site can result in increased morbidity and duration
f hospitalization (1). Therefore, the rationale for the
ransradial approach is the intention to reduce access site
leeding complications, earlier ambulation, and improved
atient comfort (2–4).
See page 1055
Despite these striking and proven advantages, the use of
he transradial route for coronary angiography or angio-
lasty in routine practice is still low. One reason for this
ould be that many studies about transradial catheterization
ere performed in high-volume centers by expert operators,
aking their results not fully applicable to the real world. In
order to assess the safety, feasi-
bility, and efficacy of transradial
catheterization, we prospectively
investigated the caseload of 4
cardiologists working in a com-
munity hospital with moderate
procedural volume.
Methods
Patient group. All patients re-
ferred for diagnostic or interven-
tional cardiac catheterization
were screened for participation.
ligible patients were randomly assigned by computer
eneration (in 2 blocks in a 1:1 ratio) to either transfemoral
r transradial catheterization. History of coronary artery
ypass surgery, cardiogenic shock, known difficulties with
he femoral (i.e., Leriche syndrome, severe peripheral artery
isease, large abdominal aortic aneurysm) or radial approach
i.e., Raynaud syndrome), simultaneous right heart cathe-
erization, a pathologic Allen’s test, necessity for a pre-
rocedural implantation of a transient pacemaker, chronic
enal insufficiency (creatinine 2.0 mg/dl) with the poten-
ial necessity of using the radial artery as a native fistula in
he future, hemodialysis patients with an arteriovenous
stula, absence of an experienced operator, or patient refusal
ere considered as exclusion criteria. All patients gave
ritten informed consent before cardiac catheterization
rocedures.
llen’s test. Allen’s test was performed by simultaneously
ccluding the radial and ulnar arteries while the patient was
bbreviations
nd Acronyms
CT  activated clotting
ime
AD  coronary artery
isease
AP  dose area product
QR  interquartile range
CI  percutaneous
oronary intervention
FH  unfractionated
eparinaking a fist. Afterwards, the patient opened the hand, and rhe ulnar artery was released. A delay of 15 s before the
eturn of color to the blanched hand was considered an
bnormal Allen’s test (5).
ascular access. Selection of the access site was individual-
zed according to the preferences of the operator and
ppropriateness of radial or femoral artery pulsations.
rossover from one arterial site to another was permitted at
ny time after randomization at the physician’s discretion.
adial sheaths for diagnostic and interventional procedures
ad a diameter of 5- and 6-F, respectively. For the transra-
ial approach, 0.3 mg isosorbide dinitrate to prevent radial
rtery spasm and 5,000 IU of unfractionated heparin (UFH)
o prevent thrombosis were injected directly into the radial
rtery through the sheath; 5-F sheaths were used for
ransfemoral diagnostic procedures. Transfemoral interven-
ions were performed using 6-F sheaths in 85% of cases and
-F in the remaining.
ascular hemostasis. Arterial sheaths were removed imme-
iately after diagnostic or interventional transradial proce-
ures while still being anticoagulated. Hemostasis was
btained using a pressure bandage with 4 elastic sticky straps
mmediately applied to the puncture site without a period of
anual compression. Patients were allowed to walk imme-
iately but not to make use of the punctured arm for the
ollowing 4 h after the procedure. The bandage was re-
oved after 6 h.
In case of transfemoral diagnostic catheterization, the
heaths were removed in the catheterization laboratory, and
emostasis was obtained by manual compression. A ban-
age was applied, and the patients were restricted to bed rest
or 6 h. After an interventional procedure via the transfemo-
al approach, vascular closure devices (Angioseal, Minne-
onka, Minnesota; StarClose SE, Redwood City, Califor-
ia) were used in 179 of the patients (93.2%). Hemostasis in
he remainder where the application of a closure device was
orbidden (severe atherosclerosis, small diameter of the
emoral artery) was achieved by manual compression fol-
owed by a bandage for an additional period of 6 h when the
ctivated clotting time (ACT) declined to 180 s.
atheterization procedures. All 4 participating interven-
ional cardiologists were required to have performed at least
0 transradial catheterizations before participation and to
ave extensive experience performing transfemoral proce-
ures. Selective catheterization of the right and left coronary
rteries was carried out followed by hand injection of the
ontrast agent. The vessels and lesions were analyzed using
computerized quantitative analysis system (Philips Med-
cal System, Eindhoven, the Netherlands) according to
reviously described and validated edge-detection algo-
ithms (2). Left ventricular ejection fraction was assessed
rom the angiogram and determined from 30° right anterior
blique projections. In case of percutaneous coronary inter-
ention (PCI), angiographic success was assumed if a
esidual stenosis in the vessel diameter of 30% with
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1049hrombolysis In Myocardial Infarction (TIMI) flow grade
according to the classification of the TIMI trial could be
chieved from the assigned access site (6).
Our institution’s laboratory is equipped with 2 single-
lane angiocardiographic systems (Allura Xper FD 10 C,
hilips, Arnheim, the Netherlands). Dose rate options are
vailable (high, normal, and low for fluoroscopy). All
perators preferentially used the low system for fluoroscopy,
hich was exclusively performed in grid-pulsed operation.
he units have digital cine with CD archiving. After
alibration, the dose area product (DAP) was measured with
n ionization chamber mounted directly at the output of the
ollimator. This device was a microprocessor-controlled
easuring system featuring 2 independent channels. DAP
easurements were expressed as Gycm2.
nticoagulant and antiplatelet regimen. After sheath inser-
ion, all patients received a bolus of 5,000-IU UFH intra-
rterially. At the end of the procedure, 5,000-IU protamine
as administered in a protamine-to-heparin ratio of 1:1
ithout measurement of ACT before removal of the fem-
ral sheath. In case of an intervention, an additional bolus of
,000-IU UFH and 500 mg aspirin were given intrave-
ously. Additional heparin was administered, if necessary,
o maintain an ACT 300 s. The use of glycoprotein
Ib/IIIa antagonists was left to the operator’s discretion. All
atients received 300-mg clopidogrel immediately after the
ntervention or the day before intervention followed by
5-mg clopidogrel and 100-mg aspirin once a day for a
eriod of 4 weeks after bare-metal stent implantation or 12
onths after drug-eluting stent implantation. Thereafter,
ll patients received aspirin 100 mg a day indefinitely.
ardiovascular risk factors. Cardiovascular risk factors were
efined as follows: history of smoking if patients had
moked within the last 10 years; hypertension, if blood
ressure 140/90 mm Hg had been documented; hyper-
holesterolemia if total cholesterol and/or low-density li-
oprotein cholesterol levels were higher than 200 mg/dl and
50 mg/dl, respectively; family history of coronary artery
isease (CAD) if myocardial infarction or coronary artery
ntervention had occurred in a first-degree relative; diabetes
as assumed if the patient took oral antidiabetic medication
r insulin or fasting blood glucose was 100 mg/dl.
tudy end points. We collected data about procedural suc-
ess rate, causes for switch to alternative access, procedural
uration, fluoroscopy time, DAP, and amount of contrast
gent. Procedural time was taken as the time of entry of the
atient into the catheterization laboratory to the end of the
rocedure. Time required for hemostasis was not included.
dditionally, vascular access site complications during hos-
italization, like pseudoaneurysm, arteriovenous fistula, ret-
operitoneal hematoma, limb ischemia, surgical vascular
epair, loss of radial artery pulse and major bleedings,
efined as a hemoglobin level decline of at least 3 g/dl or
dministration of blood transfusion, were recorded. ptatistical analysis. Clinical, angiographic and procedural
ata were prospectively entered into a computerized data-
ase. Absolute numbers and percentages are computed to
escribe the patient population. Continuous variables are
xpressed as mean  SD and are compared using the
npaired t test for normally distributed and Mann-Whitney
test for non-normally distributed variables. Categorical
ariables are expressed as absolute or relative frequencies and
re compared using chi-square analyses or the Fisher exact
est, as appropriate to the cell frequencies. Fluoroscopy time,
mount of contrast agent, DAP, and procedural duration,
hich were not normally distributed, are expressed as the
edian, together with the interquartile range (IQR). Values
f p  0.05 were considered statistically significant. SPSS
3.0 for Windows (SPSS Inc., Chicago, Illinois) was used
or statistical analysis.
esults
rom July 2006 to January 2008, a total of 2,316 patients
ere screened for participation. Of these, 1,024 patients
44.2%) with palpable femoral and radial pulses and a
ormal Allen’s test undergoing coronary artery catheteriza-
ion were randomly assigned to the transradial or trans-
emoral approach (Fig. 1). The causes for exclusion were an
schemic Allen’s test (n  347), absence of an experienced
nterventional cardiologist (n  293), history of coronary
rtery bypass surgery (n  279), chronic renal insufficiency
n  176), known severe peripheral artery disease (n  52),
atient refusal to participate in the study (n  49), simul-
aneous transient pacemaker implantation (n  34), pres-
nce of an arteriovenous fistula (n  32), known large
bdominal aortic aneurysm (n  29), and cardiogenic shock
n  1).
Baseline features of the randomized patients are ex-
ressed in Table 1. The groups were well balanced regarding
ge, sex, and body mass index. There were no significant
ifferences between both groups either in cardiovascular risk
actors (smoking, hypertension, diabetes, hypercholesterol-
mia, family history of CAD), or in terms of previous
yocardial infarction or previous PCI. Eighty-five patients
ere enrolled with acute ST-segment elevation myocardial
nfarction, 45 patients (8.8%) in the transradial group and
0 patients (7.8%) in the transfemoral group.
The angiographic data are shown in Table 2. From the
,024 randomized patients, 42 (8.2%) in the transradial
roup and 37 (7.2%) in the transfemoral group had normal
ngiograms. The extent of CAD and left ventricular ejec-
ion fraction (46  14% in the transradial group and 49 
6% in the transfemoral group; p  0.70) were similar.
Procedural results are detailed in Table 3. Successful
atheterization was achieved in 494 (96.5%) of 512 patients
n the transradial group and in 511 patients (99.8%) of 512
atients in the transfemoral group (p  0.0001). Only 1
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1050atient in the transfemoral group (0.2%) required crossover
o the transradial access because of an angiographically
roven occlusion of the abdominal aorta. The complete
Screened
n = 2316
Randomiz
n = 1024
Randomized
screened ratio 
Transradial approach 
n = 512 
Figure 1. Disposition of Patients Throughout the Study
A total of 2,316 patients were initially screened. Of those, 1,024 patients met e
transfemoral approach.
Table 1. Baseline Clinical Characteristics of the 1,024 Study Patients
Radial Group
(n  512)
Femoral Group
(n  512) p Value
Age, yrs 63.2 11.9 64.1 12.1 0.10
Male sex 292 (57.0) 309 (60.4) 0.31
Height, cm 170 9 170 9 0.79
Weight, kg 82.2 17.9 82.4 15.2 0.78
Body mass index, kg/m2 28.4 5.8 28.4 4.3 0.49
Risk factors
History of smoking 77 (15.0) 91 (17.8) 0.27
Hypercholesterolemia 235 (45.9) 228 (44.5) 0.71
Hypertension 323 (63.1) 343 (67.0) 0.21
Diabetes 132 (25.8) 127 (24.8) 0.77
Family history of CAD 82 (16.0) 76 (14.8) 0.67
Acute STEMI (12 h) 45 (8.8) 40 (7.8) 0.65
Recent MI 104 (20.3) 122 (23.8) 0.20
Previous PCI 118 (23.0) 127 (24.8) 0.56
Data presented are mean SD or n (%).
CAD  coronary artery disease; MI  myocardial infarction; PCI  percutaneous coronaryintervention; STEMI ST-segment elevation myocardial infarction.rocedure was performed via the right radial approach
ithout any problems. The 18 failed attempts in the
ransradial group (3.5%) were due to radial artery spasm
n  6), tortuosity of the innominate trunk (n  5), radial
rtery puncture failure (n  3), dilation of the ascending
Not included, n = 1292, due to 
- 347 pathologic Allen s test
- 293 absence of experienced operator 
- 279 history of CABG 
- 176 chronic renal insufficiency
-   52 severe peripheral artery disease 
-   49 patient refusal  
-   34 preprocedural pacemaker 
-   32 arteriovenous fistula 
-   29 large abdominal aneurysm  
-     1 cardiogenic shock 
Transfemoral approach 
n = 512 
ity criteria and were randomly assigned to the transradial and
Table 2. Angiographic Data
Radial Group
(n  512)
Femoral Group
(n  512) p Value
CAD, n (%) 419 (81.8) 431 (84.2) 0.36
CAD stenosis 50% 57 (11.1) 60 (11.7) 0.84
CAD stenosis 50% 362 (70.1) 371 (72.5) 0.84
1-vessel disease 93 88 0.59
2-vessel disease 113 116 0.95
3-vessel disease 156 167 0.65
Heart valve disease 8 (1.6) 4 (0.8) 0.38
Cardiomyopathy 24 (4.7) 25 (4.9) 1.00
Hypertensive heart disease 18 (3.5) 14 (2.7) 0.59
Myocarditis 1 (0.2) 1 (0.2) 1.00
Normal 42 (8.2) 37 (7.2) 0.64
LV ejection fraction, % 46 14 49 16 0.70
Data presented are mean SD, n (%), or n. 
ed
-to-
44.2%
ligibilCAD coronary artery disease; LV left ventricular.
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1051orta (n 2), lusoria artery (n 1) and inability to track the
evice in the left main (n  1). In all cases, the procedure
as successfully performed by the transfemoral approach.
The overwhelmingly large majority of PCIs were ad-hoc
ngioplasty (91.0% in the transradial group and 93.2% in
he transfemoral group; p  0.55). Overall success rate in
CI was 99.5% in the femoral group and 96.6% in the
ransradial group (p  0.06). There was 1 stent delivery
ailure due to a tortuous coronary artery in the transfemoral
roup. Causes of interventional failure in the transradial
roup were severe radial artery spasm (n  3), tortuosity of
he innominate trunk (n  2), and impossible engagement
f the left main (n  1) requiring switch to the transfemo-
al, which was performed successfully in all cases. The
ercentage of patients treated by drug-eluting stent implan-
ation was similar in both groups (23.4% in the transradial
roup and 25.7% in the transfemoral group; p  0.76).
Procedural and fluoroscopic time, amount of contrast
olume, and DAP are also shown in Table 3. Transradial
ccess (median 40.2 min, IQR 24.3 to 50.8 min) took 3.2
in longer than the transfemoral approach (median 37.0
in, IQR 19.6 to 49.1 min, p  0.046). Median fluoro-
copic time was significant longer (p  0.001) in the
ransradial group (9.0 min, IQR 3.9 to 10.7 min) compared
ith the transfemoral group (5.8 min, IQR 1.7 to 7.5 min).
edian amount of contrast agent was similar among both
roups (132 ml, IQR 80 to 160 ml in the transradial group;
29 ml, IQR 90 to 160 ml in the transfemoral group; p 
.43). Median DAP was significantly increased in the
ransradial group compared with the transfemoral access
roup (41.9 Gycm2, IQR 22.6 to 52.2 Gycm2 vs. 38.21
Table 3. Procedural Data
Transradial
(n  512)
Total procedures 512
Access failure 18 (3.5)
Diagnostic procedure 14
Interventional procedure 4
PCI 178 (34.8)
Ad-hoc PCI (% of PCI) 162 (91.0)
Drug-eluting stents 23.4
Procedural failure of PCI 6 (3.4)
Vascular closure device —
Median procedural time, min (IQR) 40.2 (24.3–50.8)
Median ﬂuoroscopy time, min (IQR) 9.0 (3.9–10.7)
Median contrast amount, ml (IQR) 132 (80–160)
Median DAP, Gycm2 (IQR) 41.9 (22.6–52.2)
Access-related complications 3 (0.58)
Cerebrovascular accidents 0 (0)
Data are presented as n, n (%), or median (IQR).
DAP dose area product; IQR interquartile range; PCI percutaneous coronary intervention.ycm2, IQR 20.4 to 48.5 Gycm2; p  0.034). (Despite the usage of vascular closure devices in 179
atients (93.2%) after transfemoral intervention, vascular
ccess site complications were higher in the transfemoral
roup (3.71%) compared with the transradial group (0.58%;
 0.0008). Pseudoaneurysms were seen in none of the
atients after transradial and in 3 patients after transfemoral
rocedure. Among these 3 patients with pseudoaneurysm, 2
f them underwent PCI with standard doses of aspirin,
eparin, clopidogrel, and glycoprotein IIb/IIIa blockers due
o ST-segment elevation myocardial infarction. All of them
ere successfully treated by ultrasound-guided thrombin
njection with complete occlusion of the pseudoaneurysm.
o patient was sent to surgery due to procedural compli-
ations. In the transfemoral group, 3 patients presented a
evere groin hematoma that required blood transfusion, 11
atients (4 after angiography and 7 after PCI) presented a
ecline of hemoglobin level of at least 3 g/dl without the
ecessity of blood transfusion, and 2 patients suffered from
n arteriovenous fistula after diagnostic angiography that
as treated conservatively. Only 3 patients (0.59%) in the
ransradial group had no beating radial artery pulse at
ischarge without any evidence of forearm ischemia. No
ases of major vascular or bleeding complications occurred
n the transradial group.
Two patients in the transfemoral group experienced
eriprocedural neurological deficit: 1 patient suffered from a
ransient ischemic attack that promptly resolved after diag-
ostic coronary angiography, whereas the other one, during
PCI procedure, had a stroke with left hemplegia that was
anaged conservatively. No deaths occurred, and 7 patients
Transfemoral
(n  512) p Value
512
1 (0.2) 0.0001
1
0
192 (37.5) 0.40
179 (93.2) 0.55
25.7 0.76
1 (0.5) 0.06
179 (93.2)
37.0 (19.6–49.1) 0.046
5.8 (1.7–7.5) 0.001
129 (90–160) 0.43
38.2 (20.4–48.5) 0.034
19 (3.71) 0.0008
2 (0.39) 0.500.68%) experienced reinfarction or repeat PCI during the
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1052n-hospital follow-up, 3 patients in the transradial group
nd 4 patients in the transfemoral group.
iscussion
he study showed that transradial coronary catheterization
s highly feasible, safe, and effective for both diagnostic and
herapeutic procedures in a standard population with the
rawback of a lower overall procedural success rate (96.5%)
s compared with the transfemoral access (99.8%; p 
.0001). In a large meta-analysis by Agostoni et al. (7), the
verall rate of procedural failure was 7.2% in the transradial
roup compared with 2.4% in the transfemoral group (odds
atio: 3.30, 95% confidence interval: 1.63 to 6.71; p 
.001). Louvard et al. (8) reported a rate of 10% in the first
0 cases, 3% to 4% after other 500 cases, whereas it
tabilizes at less than 1% only after 1,000 procedures.
onsistent with these data, the rate of transradial access
ailure in the current study was 3.5%. Due to technical
rogress of equipment and increasing expertise of the
nterventional cardiologists, a trend toward similar proce-
ural success rates could be anticipated.
ccess failure. In spite of intra-arterial administration of
itrates, spasm of the radial artery was responsible (33%) for
rocedural failure in 6 cases in our study. Its occurrence
eemed to be directly related to the duration of the proce-
ure because 3 of 6 access failures in the transradial group
wing to radial artery spasm were seen in procedures lasting
onger than 60 min. Five access failures in the transradial
roup were due to tortuosity of the innominate trunk
aking an engagement of the coronary arteries impossible.
nterestingly, a native calcification in the innominate trunk
as visible in 4 of these 5 access failures requiring a switch
o the transfemoral access route. Therefore, it is worthwhile
o perform an X-ray of this area before transradial procedure
n order to select these patients as being poor candidates for
he transradial route. Female sex seemed to be a predictor
or access failure because 13 of 18 patients (72%) with
rocedural failure were women.
rocedural duration. Transradial access is technically more
emanding and time-consuming, especially in the early
earning curve. In the current study, the procedural time in
he transradial group (40.2 min) took a little bit longer than
he transfemoral approach (37.0 min), but the difference was
ignificant (p  0.048). However, under most circum-
tances, it is unlikely that this time period would be
linically significant. Additionally, this time difference of 3.2
in did not include the time interval required for hemosta-
is, which may exceed 15 min after transfemoral catheter-
zation. The time required to obtain hemostasis using
ransradial route is markedly shorter because manual com-
ression is not necessary and the bandage could be applied
mmediately after the procedure. Therefore, procedural time roes not constitute a strong rationale for the transfemoral
pproach, especially for experienced operators.
adiation exposure. In accordance with other reports (9–13),
he fluoroscopic time in the current study was significantly
onger in the transradial group compared with the transfemoral
rocedure. This prolonged fluoroscopic time was associated
ith an increased radiation exposure of the patient. We did not
easure the DAP of the operator, but Brasselet et al. (12)
eported that the radiation exposure of the operator in a
ransradial approach was increased as well, despite using
ptimized specific protection devices, reflecting technical dif-
culties and a slightly closer position of the interventional
ardiologist to the X-ray source. This increased radiation
xposure is currently a growing problem for the health of the
nterventional cardiologist casting a shadow of caution on the
ransradial access.
ntry site complications. Access site complications are con-
iderably more frequent whenever an aggressive antiplatelet
nd/or antithrombotic treatment is needed. Consequently,
ransfemoral intervention in acute myocardial infarction
arries a risk of bleeding complications ranging from 2.5%
o 23% (10,14–16). Obesity, elderly patients, and female sex
ave also been linked to an increased occurrence of access
ite complications (17). In our study, the occurrence of groin
omplications after transfemoral catheterization could be
imited to 3.71%. Like other authors (2,4,18,19), we could
onfirm the low rate of entry site complications using the
ransradial approach, as indeed only 3 local complications
0.58%) were found in 512 patients. The radial artery is
asily compressible due to its superficial course, achieving
dequate hemostasis only with a bandage. To our knowl-
dge, this is the first randomized trial comparing access site
omplications after coronary procedures via transradial ver-
us transfemoral access with a closure device. Even with the
echnologic improvement of these devices and increasing
xperience regarding their use, we demonstrated a clear
enefit of the transradial approach as to the occurrence of
eripheral arterial complications.
In the current study, the randomized-to-screened ratio of
atients enrolled was 44.2%, and the main reason for failed
ligibility was a pathologic Allen’s test excluding 347 of
,316 screened patients (14.9%). The incidence of an
bnormal Allen’s test in patients undergoing coronary an-
iography ranges from 6.4% to 27% (20,21). But the visual
ssessment of the Allen’s test has a limited specificity
ecause of delayed recruitment of collateral flow. Studies
sing Doppler ultrasound, plethysmography, and pulse
ximetry revealed a sufficient supply by the ulnar artery in
ost patients with a pathologic Allen’s test (20,22). How-
ver, an elevated thumb capillary lactate level was measured
n these patients (23). From our point of view, transradial
atheterization should be avoided in the presence of an
bnormal Allen’s test unless the risk of using the transfemo-
al approach is exceedingly increased (e.g., severe peripheral
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1053ascular disease, morbid obesity, large abdominal aortic
neurysm, Leriche syndrome).
At discharge, we found no pulse in the cannulated radial
rtery in 3 patients (0.58%) without clinical signs of forearm
schemia. In other trials, loss of radial pulse was present in
% to 9% (4,24) without clinical sequelae. Using ultrasound
ssessment, the post-procedural absence of a radial flow was
etected in 9% (1,25), subsequently decreasing to 3% to 6%
n follow-up (4,24,26–28). The occurrence of radial occlu-
ion is a rare event, particularly if the vessel is not over-
tretched (sheath size 6-F), intra-arterial heparin is ad-
inistered without neutralization by protamine at the end
f the cannulation, the arterial sheath is withdrawn imme-
iately after the procedure, and the bandage is removed as
oon as hemostasis is achieved. Radial artery occlusion after
he transradial approach is directly related to the ratio
etween the sheath and artery size (29). Therefore, smaller
uiding catheters are potentially advantageous leading to
ess arterial spasm, pain, and post-procedural vessel occlu-
ion. However, the authors and their colleagues have shown
hat, during PCI, 5-F catheters offer no advantages con-
erning radial artery occlusion as compared with 6-F cath-
ters, with the drawback of a 7% crossover rate from 5- to
-F (30).
Although there were no redo angiographies through the
ame radial artery in the transradial group, it could be
emonstrated by Kamiya et al. (31) and Yoo et al. (32) that
fter transradial catheterization the radial artery could be
sed for both coronary artery bypass surgery as an arterial
raft and repeat catheterization.
erebral embolism. Lund et al. (33) raised concerns that
ransradial access may induce subclinical solid cerebral
icroemboli at a higher extent than the transfemoral
pproach. As assessed by magnetic resonance imaging, 15%
f patients suffered embolization toward the brain when the
atheter passed from the right arm to the aorta in those
xamined with transradial access compared with none in the
ransfemoral group (33). We could not confirm these data in
ur study. Both patients suffering from cerebral embolism
ere investigated through the femoral artery making a
etachment of larger atherosclerotic plaques from the aortic
rch most likely. To prevent cerebral embolism, we strongly
ecommend cautious manipulation and gentle advancement
f guidewires and catheters especially in the aortic arch and
he aortic-subclavian conjunction, and exchange of catheters
ver the guidewires while leaving them in the ascending
orta.
tudy limitations. We recognize that the present study has
everal limitations. First, we did not assess other important
arameters such as patient comfort, hospital stay, and the
ncidence of smaller hematomas not requiring blood trans-
usion. Second, no systematic ultrasound examination of
ost-procedural radial artery patency was performed; con-
equently, the percentage of radial occlusion, even when aadial pulse was present, may have been underestimated.
hird, as already mentioned, we did not measure the
adiation exposure of the operator. Moreover, we have to
mphasize that the data apply to a selected population
ecause only 44% of the initially screened patients could be
andomized. Finally, we used 5,000-IU heparin intrave-
ously for diagnostic procedures and an additional bolus of
,000-IU heparin for interventional procedures as antico-
gulants. Using a weight-adapted regimen with 60-IU
eparin/kg or low-molecular-weight heparin (i.e., enoxapa-
in), the frequency of access-related bleeding complications,
specially in the transfemoral group, could have been
educed.
onclusions
ransradial coronary catheterization is safe, feasible, and
ffective. However, transradial access is limited by a signif-
cantly higher rate of procedural failure. In addition, proce-
ural duration (excluding hemostasis period), fluoroscopy
ime, and radiation exposure are higher compared with
ransfemoral access. Furthermore, it does not allow the
ossibility of using other devices such as a temporary
acemaker or intra-aortic balloon pump or to perform PCI
equiring 8-F catheters. However, the radial approach
early abolishes entry site complications, in comparison
ith significantly higher rates in patients undergoing trans-
emoral catheterization. Both vascular access techniques
hould not be considered opposite or mutually exclusive, but
ather provide the interventionalist with a wider spectrum of
herapeutic options.
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